| Literature DB >> 34820789 |
Amanda J Moy1, Jessica M Schwartz2, Jennifer Withall2, Eugene Lucas1,3, Kenrick D Cato2,3,4, S Trent Rosenbloom5, Kevin Johnson5, Judy Murphy6, Don E Detmer7, Sarah Collins Rossetti1,2.
Abstract
BACKGROUND: Substantial strategies to reduce clinical documentation were implemented by health care systems throughout the coronavirus disease-2019 (COVID-19) pandemic at national and local levels. This natural experiment provides an opportunity to study the impact of documentation reduction strategies on documentation burden among clinicians and other health professionals in the United States.Entities:
Mesh:
Year: 2021 PMID: 34820789 PMCID: PMC8612869 DOI: 10.1055/s-0041-1739518
Source DB: PubMed Journal: Appl Clin Inform ISSN: 1869-0327 Impact factor: 2.342
Professional demographics among all respondents stratified by survey completion status
| Demographic variable | Complete | Incomplete | Totals |
|---|---|---|---|
|
Total
| 193 (73.1) | 71 (26.9) | 264 (100) |
|
Profession
| |||
| Informatician | 78 (40.4) | 37 (52.1) | 115 (43.6) |
| Physician | 67 (34.7) | 16 (22.5) | 83 (31.4) |
| Registered nurse | 70 (36.3) | 31 (43.7) | 101 (38.3) |
| Chief Nursing Informatics Officer/Chief Nursing Officer (CNIO/CNO) | 24 (12.4) | 5 (7) | 29 (11) |
| Researcher | 22 (11.4) | 6 (8.5) | 28 (10.6) |
| Chief Medical Information Officer/Chief Medical Officer (CMIO/CMO) | 19 (9.8) | 5 (7) | 24 (9.1) |
| Advanced practice nurse | 20 (10.4) | 5 (7.9) | 25 (9.5) |
| Educator | 20 (10.4) | 9 (12.7) | 29 (11) |
| Management | 9 (4.7) | 4 (5.6) | 13 (4.9) |
| Health care administrator | 6 (3.1) | 2 (2.8) | 8 (3) |
| Student/trainee/fellow | 5 (2.6) | 4 (5.6) | 9 (3.4) |
| Chief Clinical Informatics Officer/Chief Information Officer (CCIO/CIO) | 2 (1) | 0 (0) | 2 (0.8) |
| Physician assistant | 1 (0.5) | 1 (1.4) | 2 (0.8) |
| Behavioral scientist | 0 (0) | 1 (1.4) | 1 (0.4) |
| Pharmacist | 0 (0) | 1 (1.4) | 1 (0.4) |
| Radiologist | 0 (0) | 1 (1.4) | 1 (0.4) |
| Other | 11 (5.7) | 2 (2.8) | 13 (4.9) |
| Not specified | 0 (0) | 0 (0) | 0 (0) |
|
Setting
| |||
| Academia | 63 (32.6) | 30 (42.3) | 93 (35.2) |
| Community-based organization | 10 (5.2) | 2 (2.8) | 12 (4.5) |
| Emergency department | 6 (3.1) | 0 (0) | 6 (2.3) |
| Government | 9 (4.7) | 2 (2.8) | 11 (4.3) |
| Health IT vendor | 14 (7.3) | 7 (9.9) | 21 (8) |
| Health plan | 1 (0.5) | 1 (1.4) | 2 (0.8) |
| Health system | 92 (47.7) | 24 (33.8) | 116 (43.9) |
| Hospital | 66 (32.4) | 23 (32.4) | 89 (33.7) |
| Industry | 8 (4.1) | 8 (11.3) | 16 (6.1) |
| Military | 4 (2.1) | 1 (1.4) | 5 (1.9) |
| Nonprofit organization | 18 (9.3) | 7 (9.9) | 25 (9.5) |
| Primary care | 25 (13) | 6 (8.5) | 31 (11.7) |
| Private practice | 5 (2.6) | 0 (0) | 5 (1.9) |
| Urgent care/walk-in clinic | 2 (1) | 0 (0) | 2 (0.8) |
| Other | 11 (5.7) | 5 (7) | 16 (6.1) |
| Not specified | 1 (0.5) | 1 (1.4) | 2 (0.8) |
|
Specialty
| |||
| Internal medicine | 52 (26.9) | 13 (18.3) | 65 (24.6) |
| Pediatrics | 12 (6.2) | 9 (12.7) | 21 (8) |
| Obstetrics and gynecology | 4 (2.1) | 5 (7) | 9 (3.4) |
| Emergency medicine | 10 (5.2) | 2 (2.8) | 12 (4.5) |
| Psychiatry | 7 (3.6) | 1 (1.4) | 8 (3) |
| Surgery | 3 (1.6) | 2 (2.8) | 5 (1.9) |
| Physical medicine and rehabilitation | 1 (0.5) | 1 (1.4) | 2 (0.8) |
| Radiology | 0 (0) | 1 (1.4) | 1 (0.4) |
| Plastic surgery | 0 (0) | 1 (1.4) | 1 (0.4) |
| Radiation oncology | 0 (0) | 1 (1.4) | 1 (0.4) |
| Family medicine | 13 (6.7) | 0 (0) | 13 (4.9) |
| Anesthesiology | 3 (1.6) | 0 (0) | 3 (1.1) |
| Neurology | 2 (1) | 0 (0) | 2 (0.8) |
| Orthopaedic surgery | 2 (1) | 0 (0) | 2 (0.8) |
| Preventive medicine | 3 (1.6) | 0 (0) | 3 (1.1) |
| Ophthalmology | 1 (0.5) | 0 (0) | 1 (0.5) |
| Other | 46 (23.8) | 14 (19.7) | 60 (22.7) |
| Not applicable | 26 (13.5) | 18 (25.4) | 42 (16.7) |
| Not specified | 23 (11.9) | 8 (11.3) | 31 (11.7) |
|
Role categories
| |||
| Prescribing provider | 88 (45.6) | 21 (29.6) | 109 (41.3) |
| Registered nurse | 66 (34.2) | 30 (42.3) | 96 (36.4) |
| Other | 39 (20.2) | 20 (28.2) | 59 (22.3) |
Row percentages.
Not mutually exclusive categories (participants selected up to three choices).
Prescribing providers consist of physicians, advance practice nurses, and physician assistants.
Fig. 1Location of survey completion by state ( n = 193).
Fig. 2Distribution of co-occurring roles among respondents who completed the survey ( n = 193).
Summary of results for documentation reduction strategies experienced among completed surveys
| Experienced strategy | Prefer to remain permanent | Projected impact of strategy | Projected impact of strategy | |||
|---|---|---|---|---|---|---|
| Mean | Median | SD | ||||
|
COVID-19 documentation reduction strategies (
| ||||||
| 1. Verbal orders permitted in hospital setting | 57 (29.5) | 27 (47.4) | 118 (61.1) | 37.7 | 30 | 30 |
| 2. Waived face-to-face requirements, new physician order, and new medical necessity documentation for durable medical equipment | 66 (34.2) | 55 (83.3) | 120 (62.2) | 51.4 | 50 | 30.1 |
| 3. Changed coding for telemedicine visits for evaluation and management | 131 (67.9) | 114 (87) | 140 (72.5) | 55.8 | 60 | 33.2 |
| 4. Flexibility on quality assessment and performance improvement plans | 89 (46.1) | 57 (64) | 126 (65.3) | 54.9 | 60 | 29.6 |
| 5. Waived requirement that nursing staff develop and keep current nursing care plan for each patient | 61 (31.6) | 28 (45.9) | 120 (62.2) | 60.1 | 60 | 28.4 |
| 6. Telehealth expansion | 158 (81.9) | 143 (90.5) | – | – | ||
| a. Telehealth expansion: increased access for hospitalized patients to specialty care offsite via telemedicine | – | – | 134 (69.4) | 60.1 | 60 | 34.4 |
| b. Telehealth expansion: telehealth visit options in skilled nursing facilities and nursing facilities | – | – | 113 (58.5) | 61.4 | 70 | 32.4 |
| c. Telehealth expansion: provided telehealth services from home without reporting home address on Medicare enrollment | – | – | 112 (58) | 61.5 | 60 | 30.7 |
| 7. Disease-specific workflows such as COVID-19 express lanes or order sets | 113 (58.5) | 86 (76.1) | 141 (73.1) | 57.9 | 60 | 30.3 |
| 8. Moving laboratory testing to specialized testing centers | 60 (31.1) | 22 (36.7) | 77 (39.9) | 42.3 | 40 | 30.6 |
|
|
|
|
| |||
|
|
|
| ||||
|
Additional documentation reduction strategies (
| ||||||
| 1. Elimination of order requirement for low-risk activities/interventions (e.g., fingerstick glucose) | 29 (15) | 85 (44) | 127 (65.8) | 49.4 | 50 | 31.5 |
| 2. Reduced frequency of order resignatures | 23 (11.9) | 67 (34.7) | 111 (57.5) | 46.6 | 40 | 30.8 |
| 3. Documenting only pertinent positives to reduce note bloat | 78 (40.4) | 114 (59.1) | 140 (72.5) | 66.1 | 70 | 28.3 |
| 4. Increased use of documentation assistance (e.g., scribes or dictation) | 60 (31.1) | 81 (42) | 122 (63.2) | 60.6 | 60 | 28.1 |
| 5. Medication reconciliation can be performed by support staff | 63 (32.6) | 89 (46.1) | 121 (62.7) | 56.1 | 50 | 31.1 |
| 6. Changes to compliance rules and performance metrics to eliminate those without evidence of net benefit | 36 (18.7) | 96 (49.7) | 127 (65.8) | 65.7 | 70 | 26.3 |
| 7. Login optimization (e.g., badge log-ins, longer timeout interval) | 68 (35.2) | 113 (58.5) | 136 (70.5) | 56.5 | 60 | 33.3 |
| 8. Eliminate alerts without evidence of net benefit | 74 (38.3) | 117 (60.6) | 136 (70.5) | 59.7 | 70 | 31.8 |
| 9. Monitor and improve EHR use measures (e.g., pajama time) | 76 (39.4) | 108 (56) | 124 (64.2) | 60.2 | 65 | 29.3 |
| 10. EHR optimization sprints (rapid observation and improvement to EHR to meet workflow needs) | 84 (43.5) | 123 (63.7) | 144 (74.6) | 64.3 | 70 | 26.9 |
| 11. Device integration/efficient data capture (e.g., ventilators, home glucose monitoring, Bluetooth scale for heart failure exacerbations) | 61 (31.6) | 112 (58) | 133 (68.9) | 62.4 | 70 | 30.5 |
Abbreviations: EHR, electronic health record; SD, standard deviation.
Denominator represents those who experienced the strategy.
Fig. 3( A ) COVID-19 documentation reduction strategies experienced among completed surveys stratified by role category ( n = 193): proportion of respondents that experienced each COVID-19 documentation reduction strategy stratified by role category. ( B ) COVID-19 documentation reduction strategies experienced among completed surveys stratified by role category ( n = 193): among respondents who experienced each COVID-19 documentation reduction strategy, proportion of respondents that preferred COVID-19 documentation reduction strategy to remain permanent stratified by role category. ( C ) COVID-19 documentation reduction strategies experienced among completed surveys stratified by role category ( n = 193): average (rated) projected impact for COVID-19 documentation reduction strategy stratified by role category. *Response rates among at least one role category is <50%.
Fig. 4( A ) Additional documentation reduction strategies experienced among completed surveys stratified by role category: proportion of respondents that experienced each COVID-19 documentation reduction strategy stratified by role category. ( B ) Additional documentation reduction strategies experienced among completed surveys stratified by role category: among respondents who experienced each COVID-19 documentation reduction strategy, proportion of respondents that preferred COVID-19 documentation reduction strategy to remain permanent stratified by role category. ( C ) Additional documentation reduction strategies experienced among completed surveys stratified by role category: average (rated) projected impact for COVID-19 documentation reduction strategy stratified by role category. *Response rates among at least one role category is <50%.